Troponin News and Research

RSS

Study finds treatment disparities for men and women with chest pain

The use of a standardized tool for assessing the risk of serious outcomes in patients with chest pain was associated with women at high risk receiving comparable care to men, according to new research published in the Annals of Emergency Medicine.

23 Dec 2020

Body mass index and severe COVID-19

French researchers led by first author Abdallah Al-Salameh from the Department of Endocrinology, Diabetes Mellitus and Nutrition, Amiens University Hospital, Amiens, France, have published findings of their study titled, “The association between body mass index class and coronavirus disease 2019 outcomes,” in the latest issue of the International Journal of Obesity.

26 Nov 2020

Researchers investigate challenges of treating acute myocardial infarction caused by variant angina

In a new publication from Cardiovascular Innovations and Applications, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, China, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Ji'nan, China and Shandong First Medical University, Tai'an, China consider the challenges of treating acute myocardial infarction due to variant angina.

19 Nov 2020

ECG abnormalities can predict COVID-19 mortality

A team of scientists from New York University Langone Medical Center, USA, has revealed that the clinical severity of hospitalized patients with coronavirus disease 2019 (COVID-19) can be predicted by analyzing the level of troponin elevation and electrocardiographic (ECG) abnormalities. The study is currently available on the medRxiv preprint server.

17 Nov 2020

Potent antiplatelet drug not superior to standard of care in reducing heart attack risk during angioplasty

The use of the more potent antiplatelet medication ticagrelor was not superior to clopidogrel in the reduction of the rate of heart attack or severe complications among people undergoing an elective procedure to open a blocked artery, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Study identifies cardiac structural damage experienced by COVID-19 patients

Cardiac ultrasounds (also known as echocardiograms) are providing a view of the heart and the impact of the COVID-19 virus on patients.

27 Oct 2020

Template for COVID-19 management in a rural health system

As the COVID-19 pandemic continues to challenge existing health networks, a new study published on the preprint server medRxiv in October 2020 reports on a strategy to address existing health care disparities in rural and urban areas of the USA. This should draw attention to the need for more such systems to ensure proper rural healthcare in the current and future pandemics.

20 Oct 2020

New approach can help paramedics better identify patients at high risk for adverse cardiac events

Is this person with chest pain having a heart attack? That's a question EMTs frequently confront when responding to 911 calls.

7 Oct 2020

Risk factors for mortality among hospitalized patients with COVID-19

A new study by scientists at biotechnology company Genentech, Inc., and published on the preprint server medRxiv in September 2020 attempts to identify the factors which may shape the risk for death in COVID-19 disease.

27 Sep 2020

MIS-C linked to COVID-19 damages children's hearts

Multisystem inflammatory syndrome in children (MIS-C), believed to be linked to COVID-19, damages the heart to such an extent that some children will need lifelong monitoring and interventions, said the senior author of a medical literature review published Sept. 4 in EClinicalMedicine, a journal of The Lancet.

5 Sep 2020

ESC publishes treatment guidelines for non-ST-segment elevation acute coronary syndrome

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

31 Aug 2020

Novel saliva test could fast track heart attack diagnosis

A saliva test could fast track heart attack diagnosis, according to preliminary research presented today at ESC Congress 2020.

26 Aug 2020

Centralized medical records repository can perform data analysis and visualization

More than a decade ago, electronic medical records were all the rage, promising to transform health care and help guide clinical decisions and public health response.

19 Aug 2020

Cardiovascular disease in COVID-19

The current COVID-19 pandemic is a primarily respiratory illness, manifesting with severe hypoxia and often progressing to acute respiratory distress syndrome (ARDS) and death. However, it is also known to be linked to a wide range of cardiovascular (CV) manifestations that are associated with a very poor prognosis.

13 Aug 2020

Nanoparticle method captures and measures common marker of heart disease

Researchers at the University of Wisconsin-Madison have developed a method combining sticky nanoparticles with high-precision protein measurement to capture and analyze a common marker of heart disease to reveal details that were previously inaccessible.

7 Aug 2020

The toll that COVID-19 takes on the heart

Now, two new studies describe the toll that COVID-19 takes in the heart, increasing the risk of long-term damage even after patients recover. These studies also show that heart damage can even occur in people who did not have severe illness that required hospitalization.

29 Jul 2020

Cardiac stress caused by a marathon associated with relative exercise intensity

The European Journal of Applied Physiology has published the research in which the Universitat Jaume I participated.

27 Jul 2020

C-Path gets positive response from FDA for drug-induced skeletal muscle injury safety biomarkers

Critical Path Institute announced today that the Biomarker Qualification Program at the Center for Drug Evaluation and Research in the U.S. Food and Drug Administration issued a positive response to the Letter of Intent developed by C-Path's Predictive Safety Testing Consortium and Duchenne Regulatory Science Consortium, for a panel of four safety biomarkers of acute drug-induced skeletal muscle injury.

23 Jul 2020

SphingoTec introduces a CE-IVD-marked point-of-care test to determine blood levels of bio-ADM

Diagnostics company SphingoTec GmbH today announced the launch of its IB10 sphingotest bio-ADM, a CE-IVD-marked point-of-care test to quantitatively determine blood levels of Bioactive Adrenomedullin (bio-ADM).

22 Jul 2020

Examining cardiovascular injuries in patients who recovered from COVID-9 infection

The coronavirus disease is wreaking havoc on the health of communities throughout the world and may have lasting cardiac effects on those who have recovered from the virus.

19 Jul 2020